Abstract
Introduction: Nail unit melanoma (NUM) is a rare but aggressive malignancy with historically poor outcomes. Currently, there are no treatment guidelines for NUM. Methods: A retrospective analysis was conducted on patients diagnosed with NUM in Mexico and Brazil. Clinical and histopathological data were reviewed, and outcomes were compared between those who underwent amputation versus digit preservation surgery. Survival rates, recurrence, and functional status were assessed. Results: A total of 75 patients from Mexico (51.9%) and Brazil (48.1%) were evaluated. Clinical and pathological characteristics were similar between both groups. Functional surgery was performed in 40 patients (49.4%), including six with invasive melanomas. The median follow-up was 50.3 months (95% CI: 29.4–71.3, SE: 10.7). Among the 7 patients with invasive melanomas who underwent functional surgery, one experienced a recurrence, and one died from a cerebrovascular accident. The remaining 5 patients are alive and disease-free, with follow-up periods ranging from 1 to 27 months. Conclusions: Non-amputative surgery may be a safe alternative for thin NUMs, reducing amputation-related morbidity. Long-term follow-up and larger studies are needed to confirm guidelines.
Journal Section:
Adnexal Surgery
References
1.
Kim
BJ
, Kim
J
, Hu
J
, Kwak
Y
, Kwon
ST
. Functional surgery for subungual melanoma: surgical tips based on histological analysis of 21 cadavers
. Dermatol Surg
. 2022
;48
(1
):7
–11
. 2.
Quintella Mendes
GL
, Koifman
S
. Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: just a marker of health services accessibility
. Melanoma Res
. 2013
;23
(3
):199
–205
. 3.
Anda-Juárez
MC
, Martínez-Velasco
MA
, Fonte-Ávalos
V
, Toussaint-Caire
S
, Domínguez-Cherit
J
. Conservative surgical management of in situ subungual melanoma: long-term follow-up
. An Bras Dermatol
. 2016
;91
(6
):846
–8
. 4.
Lee
DJR
, Arbache
ST
, Quaresma
MV
, Nico
MMS
, Gabbi
TVB
. Nail apparatus melanoma: experience of 10 Years in a single institution
. Skin Appendage Disord
. 2018
;5
(1
):20
–6
. 5.
Ocampo-Garza
J
, Bretas
JM
, Matana
D
, Sobral
PJ
, Thompson
CT
, Zaiac
M
, et al. Longitudinal melanonychia biopsy: what not to do
. J Drugs Dermatol
. 2018
;17
(5
):587
–8
.6.
Tanaka
K
, Nakamura
Y
, Mizutani
T
, Shibata
T
, Tsutsumida
A
, Fukuda
H
, Dermatologic Oncology Group of the Japan Clinical Oncology Group
, et al. Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol)
. BMC Cancer
. 2019
;19
(1
):1002
. 7.
Nagore
E
, Moro
R
. Surgical procedures in melanoma: recommended deep and lateral margins, indications for sentinel lymph node biopsy, and complete lymph node dissection
. Ital J Dermatol Venerol
. 2021
;156
(3
):331
–43
. 8.
Gumaste
PV
, Fleming
NH
, Silva
I
, Shapiro
RL
, Berman
RS
, Zhong
J
, et al. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines
. J Natl Compr Canc Netw
. 2014
;12
(12
):1706
–12
. 9.
Littleton
TW
, Murray
PM
, Baratz
ME
. Subungual melanoma
. Orthop Clin North Am
. 2019
;50
(3
):357
–66
. 10.
Moehrle
M
, Metzger
S
, Schippert
W
, Garbe
C
, Rassner
G
, Breuninger
H
. Functional surgery in subungual melanoma
. Dermatol Surg
. 2003
;29
(4
):366
–74
. 11.
Nunes
LF
, Mendes
GLQ
, Koifman
RJ
. Subungual melanoma: a retrospective cohort of 157 cases from Brazilian National Cancer Institute
. J Surg Oncol
. 2018
;118
(7
):1142
–9
. 12.
Cochran
AM
, Buchanan
PJ
, Bueno
RA
Jr, Neumeister
MW
. Subungual melanoma: a review of current treatment
. Plast Reconstr Surg
. 2014
;134
(2
):259
–73
. 13.
Kostaki
M
, Plaka
M
, Stergiopoulou
A
, Kypreou
K
, Chardalia
V
, Befon
A
, et al. Subungual melanoma: the experience of a Greek melanoma reference centre from 2003 to 2018
. J Eur Acad Dermatol Venereol
. 2020
;34
(5
):e231
–4
. 14.
Reilly
DJ
, Aksakal
G
, Gilmour
RF
, Gyorki
DE
, Chauhan
A
, Webb
A
, et al. Subungual melanoma: management in the modern era
. J Plast Reconstr Aesthet Surg
. 2017
;70
(12
):1746
–52
. 15.
Chakera
AH
, Quinn
MJ
, Lo
S
, Drummond
M
, Haydu
LE
, Bond
JS
, et al. Subungual melanoma of the hand
. Ann Surg Oncol
. 2019
;26
(4
):1035
–43
. 16.
Ren
M
, Ren
J
, Cai
X
, Shen
XX
, Kong
JC
, Dai
B
, et al. Clinicopathological, immunohistochemical and fluorescence in-situ hybridisation features of early subungual melanoma: an analysis of 65 cases
. Histopathology
. 2021
;78
(5
):717
–26
. 17.
Flores-Terry
M
, Romero-Aguilera
G
, Mendoza
C
, Franco
M
, Cortina
P
, Garcia-Arpa
M
, et al. Functional surgery for malignant subungual tumors: a case series and literature review
. Actas Dermosifiliogr
. 2018
;109
(8
):712
–21
. 18.
Tanaka
K
, Nakamura
Y
, Mizutani
T
, Shibata
T
, Tsutsumida
A
, Fukuda
H
, Dermatologic Oncology Group of the Japan Clinical Oncology Group
, et al. Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol)
. BMC Cancer
. 2019
;19
(1
):1002
. 19.
Ko
D
, Oromendia
C
, Scher
R
, Lipner
SR
. Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy
. J Am Acad Dermatol
. 2019
;80
(5
):1272
–83
. 20.
Hirata
SH
, Yamada
S
, Enokihara
MY
, Di Chiacchio
N
, de Almeida
FA
, Enokihara
MMSS
, et al. Patterns of nail matrix and bed of longitudinal melanonychia by intraoperative dermatoscopy
. J Am Acad Dermatol
. 2011
;65
(2
):297
–303
. 21.
Di Chiacchio
ND
, Farias
DCD
, Piraccini
BM
, Hirata
SH
, Richert
B
, Zaiac
M
, et al. Consensus on melanonychia nail plate dermoscopy
. An Bras Dermatol
. 2013
;88
(2
):309
–13
. 22.
Nguyen
JT
, Bakri
K
, Nguyen
EC
, Johnson
CH
, Moran
SL
. Surgical management of subungual melanoma: mayo clinic experience of 124 cases
. Ann Plast Surg
. 2013
;71
(4
):346
–54
. 23.
Shin
HT
, Jang
KT
, Mun
GH
, Lee
DY
, Lee
JB
. Histopathological analysis of the progression pattern of subungual melanoma: late tendency of dermal invasion in the nail matrix area
. Mod Pathol
. 2014
;27
(11
):1461
–7
. 24.
Romano
RC
, Shon
W
, Sukov
WR
. Malignant melanoma of the nail apparatus: a fluorescence in situ hybridization analysis of 7 cases
. Int J Surg Pathol
. 2016
;24
(6
):512
–8
. 25.
Swetter
SM
, Thompson
JA
, Albertini
MR
, Barker
CA
, Baumgartner
J
, Boland
G
, et al. NCCN Guidelines® insights: melanoma: cutaneous, version 2.2021
. J Natl Compr Canc Netw
. 2021
;19
(4
):364
–76
. 26.
Michielin
O
, van Akkooi
ACJ
, Ascierto
PA
, Dummer
R
, Keilholz
U
, ESMO Guidelines Committee Electronic address clinicalguidelines@esmo org
. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
. Ann Oncol
. 2019
;30
(12
):1884
–901
. 27.
Swetter
SM
, Tsao
H
, Bichakjian
CK
, Curiel-Lewandrowski
C
, Elder
DE
, Gershenwald
JE
, et al. Guidelines of care for the management of primary cutaneous melanoma
. J Am Acad Dermatol
. 2019
;80
(1
):208
–50
. 28.
Nakamura
Y
, Ohara
K
, Kishi
A
, Teramoto
Y
, Sato
S
, Fujisawa
Y
, et al. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma
. J Dermatol
. 2015
;42
(9
):861
–6
. 29.
Haddock
NT
, Wilson
SC
, Shapiro
RL
, Choi
M
. Wide local en bloc excision of subungual melanoma in situ
. Ann Plast Surg
. 2014
;73
(6
):640
–4
. 30.
Seyed Jafari
SM
, Lieberherr
S
, Cazzaniga
S
, Beltraminelli
H
, Haneke
E
, Hunger
RE
. Melanoma of the nail apparatus: an analysis of patients’ survival and associated factors
. Dermatology
. 2022
;238
(1
):156
–60
. 31.
Nakamura
Y
, Fujisawa
Y
, Teramoto
Y
, Sato
S
, Yamada
K
, Sekine
K
, et al. Tumor-to-bone distance of invasive subungual melanoma: an analysis of 30 cases
. J Dermatol
. 2014
;41
(10
):872
–7
. 32.
Mundada
P
, Becker
M
, Lenoir
V
, Stefanelli
S
, Rougemont
AL
, Beaulieu
JY
, et al. High resolution MRI of nail tumors and tumor-like conditions
. Eur J Radiol
. 2019
;112
:93
–105
. 33.
Ogata
D
, Uhara
H
, Tsutsumida
A
, Yamazaki
N
, Mochida
K
, Amano
M
, et al. Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 cases
. Eur J Dermatol
. 2017
;27
(6
):620
–6
. 34.
Littleton
TW
, Murray
PM
, Baratz
ME
. Subungual melanoma
. Orthop Clin North Am
. 2019
;50
(3
):357
–66
. 35.
Ohn
J
, Jo
G
, Cho
Y
, Sheu
SL
, Cho
KH
, Mun
JH
. Assessment of a predictive scoring model for dermoscopy of subungual melanoma in situ
. JAMA Dermatol
. 2018
;154
(8
):890
–6
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
